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  MICROTITRIMETRIC DETERMINATION OF A 
DRUG CONTENT OF PHARMACEUTICALS 
CONTAINING OLANZAPINE IN 
NON-AQUEOUS MEDIUM 
Two simple, rapid, reliable and cost-effective methods based on titrimetry in 
non-aqueous medium are described for the determination of olanzapine in 
pharmaceuticals. In these methods, the drug dissolved in the glacial acetic 
acid was titrated with the acetous perchloric acid with visual and potentiometric 
end point detection, crystal violet being used as the indicator for visual titration. 
The methods are applicable over 1-15 mg range of olanzapine. The proce-
dures were applied to determine olanzapine in pharmaceutical products and 
the results were found to be in a good agreement with those obtained by the 
reference method. Associated pharmaceutical materials did not interfere. The 
precision results, expressed by inter-day and intra-day relative standard de-
viation values, were satisfactory, higher than 2%. The accuracy was satisfac-
tory as well. The methods proved to be suitable for the analysis of olanzapine 
in bulk drug and in tablets. The accuracy and reliability of the methods were 
further ascertained by recovery studies via a standard addition technique with 
percent recoveries in the range 97.51-103.7% with a standard deviation of less 
than 2%. 
Key words: olanzapine; assay; titrimetry; non-aqueous; crystal violet; 
potentiometry; pharmaceuticals. 
 
 
Olanzapine (OLP), chemically known as 2-me-
thyl-10-(4-methyl-piperazin-1-yl)-4H-3-thio-4,9-diaza- 
-benzo[f]azulene (Fig. 1) is an atypical antipsychotropic 
drug. It is the most commonly prescribed second-ge-
neration neuroleptic for the treatment of psychiatric 
patients suffering from schizophrenia. The need for 
reliable, sensitive, and fast methods for its analysis in 
bulk samples and pharmaceutical preparations, as 
been obvious since its introduction in a therapy of 
psychiatric disorders in 1997. 
 
Fig. 1. Structure of olanzapine. 
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Only a limited number of analytical methods for 
the quantitative determination of OLP in pharmaceu-
tical preparations are known such as UV-spectropho-
tometry [1,2], visible spectrophotometry [3], flow in-
jection spectrophotometry [4], kinetic spectrophoto-
metry [5], HPLC [6], HPTLC [7] and capillary zone 
electrophoresis and linear voltammetry [1]. Many re-
ported methods are sensitive but time consuming and 
require expensive instrumental set-up and some pre-
liminary treatment. 
Despite its simplicity, versatility and long history, 
there is only one report on the use of the technique for 
the assay of OLP. Firdous et al. [2] have developed a 
non-aqueous titrimetric method using 0.10 N HClO4 
as titrant and naphthobenzene as an indicator. Though 
the method is reported to be accurate with a percent 
recovery of 99.0-100.67% and precise with an inter- 
-day precision of 0.35%, it is applicable to macrosize 
samples. 
This paper proposes two non-aqueous titrimetric 
procedures based on the basic property of the drug 
molecule in which the drug solution in glacial acetic 
acid is titrated directly with acetous perchloric acid, 
the end point being determined either visually using a 
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crystal violet indicator or potentiometrically using a 
modified glass-saturated calomel electrode system. 
The methods, in addition to being rapid, sensitive (ap-
plicable over 1-15 mg range), accurate and precise, 
gave satisfactory results when applied to formulations 
containing OLP. Additionally, the methods can be 
used in laboratories where modern and expensive 
instruments are not available.  
EXPERIMENTAL 
Materials and Methods 
Apparatus 
Potentiometric titration was performed with an 
Elico 120 digital pH meter provided with a combined 
glass-SCE electrode system. The KCl of the salt bridge 
was replaced with 0.10 M methanolic KCl. 
Reagents and solutions 
All chemicals used were of analytical reagent 
grade. All solutions were made in glacial acetic acid, 
unless mentioned otherwise. 
Perchloric acid 
The stock solution of (≈0.1 M) perchloric acid (S. 
D. Fine Chem., Mumbai, India) was diluted appropria-
tely with glacial acetic acid to get a working solution of 
0.010 M perchloric acid and standardized with pure 
potassium hydrogen phthalate by using crystal violet 
as the indicator [8]. 
Crystal violet indicator (0.10%) 
Prepared by dissolving 50 mg of the dye (S. D. 
Fine Chem., Mumbai, India) in 50 mL glacial acetic 
acid. 
Standard drug solution 
Phramaceutical grade olanzapine (OLP) was 
procured from Cipla India Ltd, Mumbai, India, as a 
gift, and was used as received. A stock standard so-
lution containing 1 mg mL-1 OLP was prepared by 
dissolving 250 mg of pure drug in glacial acetic acid 
and diluting to the mark in a 250 mL calibrated flask 
with the same solvent. 
General Procedures 
Visual titration (method A) 
An aliquot of the drug solution containing 1-15 
mg of OLP was pipetted out into a clean and dry 100 
mL titration flask and the total volume was brought to 
15 mL by glacial acetic acid. Two drops of the crystal 
violet indicator were added and titrated with standard 
0.010 M perchloric acid to a blue colour end point. 
The amount of the drug in the measured aliquot was 
calculated from  
Amount (mg) = VMwR/n 
where V = volume of perchloric acid required, mL; 
Mw = relative molecular mass of the drug; R = molarity 
of the perchloric acid and n = number of moles of 
perchloric acid reacting with each mole of OLP. 
Potentiometric titration (method B) 
An aliquot of the standard drug solution equi-
valent to 1-15 mg of OLP was pipetted out into a 
clean and dry 100 mL beaker and the solution was 
diluted to 20 mL by adding glacial acetic acid. The 
combined glass-SCE (modified) system was dipped in 
the solution. The contents were stirred magnetically 
and the titrant (0.010 M HClO4) was added from a 
microburette. Near the equivalence point, titrant was 
added in 0.10 mL increments. After each addition of 
titrant, the solution was stirred magnetically for 30 s 
and the steady potential was noted. The addition of 
titrant was continued until there was no significant 
change in potential on further addition of titrant. The 
equivalence point was determined by applying the 
graphical method. The amount of the drug in the 
measured aliquot was calculated as described under 
visual titration. 
Procedure for tablets 
Oleanz 10 (Cipla India Ltd, Mumbai, India), Ole-
anz 20 (Cipla India Ltd, Mumbai, India) and Opin 10 
(Sun pharmaceutical Ltd), all tablets, were used in the 
investigation. 
Twenty tablets were weighed and ground into a 
fine powder. An amount of the powder equivalent to 
100 mg of OLP was weighed accurately into a 100 mL 
calibrated flask, 70 mL of glacial acetic acid was ad-
ded and shaken for about 20 min. Then glacial acetic 
acid was added to the mark, mixed well and filtered 
using Whatmann No 42 filter paper. The first 10 mL 
portion of the filtrate was discarded. A suitable aliquot 
was next subjected to analysis by titrimetry as des-
cribed earlier. 
RESULTS AND DISCUSSIONS 
The present methods are based on the neutra-
lization reaction involving the basic property of OLP 
and employ two techniques. The methods are based 
on the principle that substances, which are weakly 
basic in aqueous medium, exhibit enhanced basicity 
in non-aqueous media thus allowing their easy deter-
mination. In the present titrimetric methods, the weak-
ly basic property of OLP was enhanced due to the 
non-leveling effect of glacial acetic acid and titrated 
with perchloric acid with visual and potentiometric end 
point detection. Crystal violet gives satisfactory end 
point for the concentrations of analyte and titrant em-
ployed. A steep rise in the potential was observed at 
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the equivalence point with the potentiometric end 
point detection (Fig. 2). With both methods of the 
equivalence point detection, a reaction stoichiometry 
of 1:2 (drug:titrant) was obtained which served as the 
basis for calculation. Using 0.010 M perchloric acid, 
1-15 mg of OLP was conveniently determined. The 
relationship between the drug amount and the titration 
end point was examined. The linearity between two 
parameters is apparent from the correlation coeffi-
cients of 0.9986 and 0.9996 obtained by the method 
of least squares for visual and potentiometric me-
thods, respectively. From this, it is implied that the 
reaction between OLP and perchloric acid proceeds 
stoichiometrically in the ratio 1:2 in the range studied 
(1-15 mg). 
Validation 
The optimized methods were completely vali-
dated according to the procedures described in ICH 
guidelines for the validation of analytical methods [9]. 
Intra-day and inter-day accuracy and precision 
The precision of the methods was evaluated in 
terms of the intermediate precision (intra-day and 
inter-day). Three different concentrations of OLP with-
in the range of study in each method were analyzed in 
seven and five replicates with respect to method A 
and B during the same day (intra-day precision) and 
five consecutive days (inter-day precision). For inter- 
-day precision, each day analysis was performed in 
triplicate and pooled-standard deviation was calcu-
lated. The RSD values of intra-day and inter-day stu-
dies for OLP showed that the precision of the me-
thods was good (Table 1). The accuracy of the me-
thods was determined by the percent mean deviation 
from the known concentration, bias (%) = [(Concen-
tration found - known concentration)×100/known con-
centration]. Bias was calculated at each concentration 
and these results are also presented in Table 1. 
Ruggedness of the methods 
Method ruggedness was expressed as the RSD 
of the same procedure applied by four different 
analysts as well as using four different burettes. The 
inter-analysts RSD were within 3% whereas the inter-
burettes RSD for the same OLP concentrations ran-
ged from 1.0% suggesting that the developed method 
was rugged. The results are shown in Table 2. 
 
 
Fig. 2. Potentiometric titration curves for 10 mg OLP vs. 0.010 M HClO4. 
Table 1. Intra-day and inter-day accuracy and precision evaluation 
Method 
OLP taken 
mg 
Accuracy and precision 
Intra-day Inter-day 
OLP found, mg RE, % RSD, % OLP found, mg RE, % RSD, % 
Visual titrimetry 
(n = 7) 
4.0 
8.0 
12.0 
4.04 
7.91 
12.2 
1.00 
1.13 
1.60 
0.85 
0.64 
0.72 
3.95 
8.07 
11.87 
1.24 
0.86 
1.05 
1.42 
1.38 
1.18 
Potentiometric 
titrimetry (n = 5) 
4.0 
8.0 
12.0 
4.05 
8.11 
12.20 
1.20 
1.40 
1.33 
0.42 
0.28 
0.56 
4.02 
8.10 
11.86 
1.65 
1.37 
1.14 
1.85 
1.73 
1.26 
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Application 
 The proposed methods were successfully ap-
plied to determine OLP in tablets. The same tablets 
were analyzed by an established procedure [2] for 
comparison. In the reference method, the tablet ex-
tract in methanol was prepared and its absorbance 
was measures at 226 nm. The results obtained by the 
proposed methods agree well with those of the refe-
rence method [2] and with the label claim. The results 
were also compared statistically by a Student’s t-test 
for accuracy and by a variance F-test for precision 
with those of the reference method at 95% confidence 
level as summarized in Table 3. The results showed 
that the calculated t  and F values did not exceed the 
tabulated values inferring that proposed methods are 
as accurate and precise as the reference method. 
Recovery study 
The accuracy and reliability of the methods were 
further ascertained by performing recovery experi-
ments. To a fixed amount of drug in formulation (pre- 
-analyzed), pure drug at three different levels was 
added, and the total was found by the proposed 
methods. Each test was repeated three times. The 
results compiled in Table 4 show that recoveries were 
in the range 99.5 to 103% indicating that commonly 
added excipients to tablets such as talc, starch, ge-
latin, sodium alginate, magnesium stearate, calcium 
gluconate and calcium dihydrogen orthophosphate, 
did not interfere in the determination. 
 
Table 2. Method ruggedness expressed as intermediate precision (% RSD) 
Mehod OLP taken, mg 
Ruggedness 
Inter-Analysts (n = 4) Inter-burettes (n = 4) 
Visual titrimetry 
(n = 7) 
4.0 
8.0 
12.0 
1.75 
2.12 
2.46 
0.64 
0.72 
0.36 
Potentiometric titrimetry 
(n = 5) 
4.0 
8.0 
12.0 
2.26 
2.52 
1.84 
0.28 
0.14 
0.39 
    
Table 3. Results of the analysis of tablets containing OLP by the proposed methods and comparison with the reference method 
Tablet used Label claim, mg/tablet 
% Found±SD* 
Reference method [2] 
Proposed methods 
Visual titrimetry Potentiometric titrimetry 
Oleanz 10 10 101.3±0.85 102.5±1.14 
t = 1.9 
F = 1.80 
102.8±0.96 
t = 2.62 
F = 1.28 
Oleanz 20 20 97.58±0.66 98.14±0.62 
t = 1.38 
F = 1.13 
97.06±0.36 
t = 1.61 
F = 3.36 
Opin 10 10 98.33±0.72 99.42±0.85 
t = 2.19 
F = 1.39 
100.1±0.44 
t = 4.82 
F = 2.68 
*Average of five determinations 
Table 4. Results of the recovery study using the standard addition method 
Tablet 
studied 
Visual titrimetry Potentiometric titrimetry 
OLP in tablet 
extract, mg 
Amount of pure 
OLP added, mg 
Total OLP 
found, mg
Pure OLP reco-
vered*, % 
OLP in tablet 
extract, mg 
Amount of pure 
OLP added, mg 
Total OLP 
found, mg 
Pure OLP reco-
vered*, % 
Oleanz 20 4.1 
4.1 
4.1 
2.0 
4.0 
6.0 
6.15 
8.06 
10.0 
102.5±0.63 
99.04±0.72 
98.30±1.12 
4.11 
4.11 
4.11 
2.0 
4.0 
6.0 
6.18 
8.12 
10.08 
103.6±0.62 
100.3±1.04 
99.58±0.72 
Opin 10 3.98 
3.98 
3.98 
2.0 
4.0 
6.0 
5.93 
7.95 
9.90 
97.51±0.71 
99.33±0.96 
98.72±0.58 
4.0 
4.0 
4.0 
2.0 
4.0 
6.0 
6.02 
8.01 
10.22 
101.2±0.67 
100.3±0.92 
103.7±1.36 
*Mean value of three determination 
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CONCLUSIONS 
Although several instrumental techniques [1-7] 
have been reported for the assay of olanzapine in 
pharmaceuticals they suffer from such draw backs as 
high cost, multiple extraction steps and also several 
clean-up steps (HPLC). They are time consuming and 
often poorly reproducible. In contrast, the proposed 
titrimetric methods are rapid, simple, precise and ac-
curate; and above all, inexpensive. The previous non-
-aqueous titrimetric assay of olanzapine [2] is appli-
cable for samples containing 50 mg active ingredient. 
In contrast, the present methods can be used over a 
semimicro scale (1-15 mg) thus offering an additional 
cost advantage. Hence, the proposed methods can 
serve as useful reference methods for routine assay 
as a part of industrial quality control. 
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